Search

Your search keyword '"G. CABIBBO"' showing total 26 results

Search Constraints

Start Over You searched for: Author "G. CABIBBO" Remove constraint Author: "G. CABIBBO" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
26 results on '"G. CABIBBO"'

Search Results

1. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma.

2. What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis.

3. Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma.

4. Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.

6. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.

7. Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.

9. Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals.

10. Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization?

11. The changing scenario of hepatocellular carcinoma in Italy: an update.

12. Monofocal hepatocellular carcinoma: How much does size matter?

13. The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study.

14. Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?

15. Metabolic disorders across hepatocellular carcinoma in Italy.

16. Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study.

17. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.

18. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.

19. Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.

20. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.

21. Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma.

22. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.

23. Should cirrhosis change our attitude towards treating non-hepatic cancer?

24. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.

26. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems.

Catalog

Books, media, physical & digital resources